Search for: "Applied Biological Laboratories, Inc."
Results 61 - 80
of 90
Sorted by Relevance
|
Sort by Date
18 Apr 2008, 2:00 am
, Global Global - General Candidates for post of WIPO Director General present their platforms: (WIPO), IP is not a thing: (Dilanchian), FOSS adoption and consumer welfare: (IPcentral) Global - Trade Marks / Domain Names / Brands Manufacturers becoming brand licensing companies: (IP ThinkTank), Anti-Counterfeiting Trade Agreement moves forward: (Michael Geist) Global - Patents Office Open XML voted to become official standard, so out of Microsoft’s hands: (Ars… [read post]
23 Dec 2023, 7:16 pm
Back in 1985, in connection with Agent Orange litigation, the late Judge Jack Weinstein wrote what was correct then, and even more so today, that “laboratory animal studies are generally viewed with more suspicion than epidemiological studies, because they require making the assumption that chemicals behave similarly in different species. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
7 Jun 2010, 9:54 am
– Center for Biological Diversity, June 4, 2010 A federal judge yesterday approved a settlement that requires the federal government to finalize protections for seven penguin species under the Endangered Species Act. [read post]
7 Jun 2010, 10:04 am
– Center for Biological Diversity, June 4, 2010 A federal judge yesterday approved a settlement that requires the federal government to finalize protections for seven penguin species under the Endangered Species Act. [read post]
7 Jun 2007, 10:52 am
Whitehall Laboratories, Inc., 874 F. [read post]
11 Nov 2022, 9:40 am
Abbott Laboratories, 636 F.3d 1341(Fed. [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
7 Apr 2010, 3:44 pm
Click Here EPA Settles with Drug and Laboratory Disposal on Hazardous Waste Violations. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will address patent… [read post]
26 Jun 2012, 8:24 am
In re Pfizer Inc. [read post]
6 May 2010, 4:12 pm
Abbott Laboratories, 397 F. [read post]
19 Apr 2021, 10:20 am
Heather Pringle, commander of the Air Force research laboratory; Rear Adm. [read post]
13 Nov 2008, 1:52 pm
Abbott Laboratories, 607 P.2d 924, (Cal. 1980). [read post]
16 Oct 2009, 3:18 pm
FDA intends to apply a standard for the substantiation of dietary supplement claims that is consistent with the FTC approach. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007:… [read post]
